NYSE:CAH - Cardinal Health Stock Price, Forecast & News

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health declared a quarterly dividend on Thursday, November 7th. Stockholders of record on Thursday, January 2nd will be paid a dividend of $0.481 per share on Wednesday, January 15th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 3.57%. The ex-dividend date of this dividend is Tuesday, December 31st. View Cardinal Health's Dividend History.

Cardinal Health announced that its Board of Directors has initiated a stock repurchase plan on Thursday, November 8th 2018, which authorizes the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 6.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board believes its shares are undervalued.

Cardinal Health Inc (NYSE:CAH) issued its earnings results on Thursday, November, 7th. The company reported $1.27 EPS for the quarter, beating the Zacks' consensus estimate of $1.09 by $0.18. The business earned $37.34 billion during the quarter, compared to analyst estimates of $36.75 billion. Cardinal Health had a positive return on equity of 32.25% and a negative net margin of 2.81%. The firm's revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.29 EPS. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Cardinal Health.

Cardinal Health will be holding an earnings conference call on Thursday, February 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Cardinal Health updated its FY 2020 Pre-Market earnings guidance on Monday, November, 25th. The company provided EPS guidance of $4.85-5.10 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.99.

6 equities research analysts have issued 12 month price objectives for Cardinal Health's shares. Their forecasts range from $41.00 to $55.00. On average, they anticipate Cardinal Health's share price to reach $49.25 in the next year. This suggests that the stock has a possible downside of 8.7%. View Analyst Price Targets for Cardinal Health.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cardinal Health.

News coverage about CAH stock has been trending positive recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cardinal Health earned a coverage optimism score of 2.5 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Cardinal Health.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), Exxon Mobil (XOM), CVS Health (CVS), Becton Dickinson and (BDX), General Electric (GE), PepsiCo (PEP), Verizon Communications (VZ) and Gilead Sciences (GILD).

Cardinal Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Kempner Capital Management Inc. (0.04%), Kwmg LLC (0.03%), Advisors Capital Management LLC (0.02%), United Services Automobile Association (0.02%), DNB Asset Management AS (0.02%) and Sage Capital Advisors llc (0.02%). Company insiders that own Cardinal Health stock include Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Zeke Capital Advisors LLC, United Services Automobile Association, State of Alaska Department of Revenue, Advisors Capital Management LLC, Livingston Group Asset Management CO operating as Southport Capital Management, Welch & Forbes LLC, Sawyer & Company Inc and Buckley Wealth Management LLC. View Insider Buying and Selling for Cardinal Health.

CAH stock was bought by a variety of institutional investors in the last quarter, including Sage Capital Advisors llc, DNB Asset Management AS, CLARET ASSET MANAGEMENT Corp, Alpine Global Management LLC, LFA Lugano Financial Advisors SA, Cozad Asset Management Inc., IMS Capital Management and Trilogy Capital Inc.. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $53.95.

Cardinal Health has a market capitalization of $15.78 billion and generates $145.53 billion in revenue each year. The company earns $1.36 billion in net income (profit) each year or $5.28 on an earnings per share basis. Cardinal Health employs 31,000 workers across the globe.View Additional Information About Cardinal Health.

The official website for Cardinal Health is http://www.cardinalhealth.com/.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]